Medinotec Inc. (MDNC) — SEC Filings
Medinotec Inc. (MDNC) — 12 SEC filings. Latest: 10-Q (Oct 8, 2025). Includes 6 10-Q, 4 8-K, 2 10-K.
View Medinotec Inc. on SEC EDGAR
Overview
Medinotec Inc. (MDNC) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Oct 8, 2025: Medinotec Inc. reported significant revenue growth for the six months ended August 31, 2025, reaching $5,370,331, a substantial increase from $3,055,897 in the prior year period. Net income also rose to $460,350 for the six-month period, up from $371,953 in the same period last year. The company's g
Sentiment Summary
Across 12 filings, the sentiment breakdown is: 1 bearish, 9 neutral, 2 mixed. The dominant filing sentiment for Medinotec Inc. is neutral.
Filing Type Overview
Medinotec Inc. (MDNC) has filed 6 10-Q, 2 10-K, 4 8-K with the SEC between Feb 2024 to Oct 2025.
Filings by Year
Recent SEC Filings (12)
| Date | Form | Description | Risk |
|---|---|---|---|
| Oct 8, 2025 | 10-Q | Medinotec's Revenue Soars 76% Amidst Rising Operating Costs | medium |
| Jul 16, 2025 | 10-Q | Medinotec's Revenue Soars 600% on Minion Medical Boost | medium |
| May 29, 2025 | 10-K | Medinotec's Revenue Soars 900% on Single Customer Reliance | high |
| Jan 27, 2025 | 8-K | Medinotec Inc. Files 8-K for Regulation FD and Financials | low |
| Jan 14, 2025 | 10-Q | Medinotec Inc. Files Q3 2024 10-Q | low |
| Oct 15, 2024 | 10-Q | Medinotec Inc. Files Q2 2024 10-Q Report | low |
| Jul 12, 2024 | 10-Q | Medinotec Inc. Files Q1 2024 10-Q Report | low |
| Jul 10, 2024 | 8-K | Medinotec Inc. Changes Certifying Accountant | low |
| Jul 5, 2024 | 10-K | Medinotec Inc. Files 2024 10-K | low |
| Mar 19, 2024 | 8-K | Medinotec Inc. Files 8-K on Security Holder Vote | low |
| Mar 14, 2024 | 10-Q | Medinotec Inc. Files 10-Q for Period Ending November 30, 2023 | low |
| Feb 26, 2024 | 8-K | Medinotec Files 8-K: Regulation FD Disclosure & Financial Exhibits | low |
Risk Profile
Risk Assessment: Of MDNC's 12 recent filings, 1 were flagged as high-risk, 2 as medium-risk, and 9 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $5.37M |
| Net Income | $460,350 |
| EPS | $0.04 |
| Debt-to-Equity | 0.30 |
| Cash Position | $2.25M |
| Operating Margin | 26.7% |
| Total Assets | $6.37M |
| Total Debt | $0.44M |
Industry Context
Medinotec operates within the medical device manufacturing sector, which is characterized by rigorous regulatory oversight, significant R&D investment, and a competitive landscape. The company's focus on specialized respiratory devices, like the Trachealator, positions it within a niche segment. Success hinges on technological innovation, FDA approvals, and effective market penetration strategies, particularly in expanding into new geographic markets like the U.S.
Top Tags
10-Q (4) · Revenue Growth (3) · quarterly-report (3) · Medical Devices (2) · South Africa (2) · Customer Concentration (2) · Medical Instruments (2) · SEC Filing (2) · regulation-fd (2) · financial-statements (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Revenue | $5.37M | Increased from $3.06M for the six months ended August 31, 2024 |
| Net Income | $460,350 | Increased from $371,953 for the six months ended August 31, 2024 |
| Gross Profit | $2.93M | Increased from $1.43M for the six months ended August 31, 2024 |
| Sales and Marketing Expenses | $696,177 | Increased from $43,451 for the six months ended August 31, 2024 |
| General and Administrative Expenses | $1.30M | Increased from $631,014 for the six months ended August 31, 2024 |
| Cash and Cash Equivalents | $2.25M | Decreased from $2.77M as of February 28, 2025 |
| Repayment of Debt | $980,467 | Cash outflow from financing activities for the six months ended August 31, 2025 |
| Common Shares Outstanding | 11,755,548 | As of October 8, 2025 |
| Basic Earnings Per Share | $0.04 | For the six months ended August 31, 2025, up from $0.03 |
| Revenue Growth | 75.7% | Percentage increase for the six months ended August 31, 2025, compared to the prior year |
| Total Revenue | $1.05M | Increased 600% from $150,000 in the prior year period. |
| Revenue from One Customer | $900K | Represents 85.7% of total revenue, indicating high customer concentration. |
| Outside USA Internally Designed/Manufactured Sales | $150K | Contribution to total revenue for the current quarter. |
| Outside USA Internally Designed Manufactured Sales | $500,000 | Significant component of 2025 revenue, showing international sales focus. |
| Inside USA Internally Designed Manufactured Sales | $300,000 | Contribution to 2025 revenue, indicating domestic market presence. |
Frequently Asked Questions
What are the latest SEC filings for Medinotec Inc. (MDNC)?
Medinotec Inc. has 12 recent SEC filings from Feb 2024 to Oct 2025, including 6 10-Q, 4 8-K, 2 10-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of MDNC filings?
Across 12 filings, the sentiment breakdown is: 1 bearish, 9 neutral, 2 mixed. The dominant sentiment is neutral.
Where can I find Medinotec Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Medinotec Inc. (MDNC) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Medinotec Inc.?
Key financial highlights from Medinotec Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for MDNC?
The investment thesis for MDNC includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Medinotec Inc.?
Executive information for Medinotec Inc. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Medinotec Inc. stock?
Of MDNC's 12 assessed filings, 1 were flagged high-risk, 2 medium-risk, and 9 low-risk.
What are recent predictions and forward guidance from Medinotec Inc.?
Forward guidance and predictions for Medinotec Inc. are extracted from SEC filings as they are enriched.